9th CAR-TCR Summit

The commercial success of cell therapies is continuing to grow! With a recent TIL approval, a shift to earlier line CAR-T treatment, and further approvals set for this year, 2024 will be pivotal to demonstrate the clinical benefit of cell therapies and advance breakthroughs in solid tumors and autoimmunity.

That’s why now’s the time to join the 9^th CAR-TCR Summit: the industry’s definitive forum committed to progressing end-to-end cell therapy development. This year’s 2-day conference will accommodate in-depth tracks covering Discovery, Translation, Clinical Development, Early-Stage Manufacturing, Late-Stage Manufacturing, Analytical Development and Supply Chain & Clinical Operations.

This is your team’s one-stop shop for all functions to discover cutting-edge innovations, significant clinical data and gain insights into how to conquer the bottlenecks withholding optimal durability, accessibility, safety and cost-efficiency.

Join 130+ expert speakers and 1,000+ cell therapy experts to collaborate to achieve the shared goal of delivering these curative treatments to the ever-growing population of patients in need.

To see the speaker faculty, what’s new for 2024, full session details, who you will meet and much more, view the full agenda now: https://ter.li/wjnrky